相似文献
1
VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.
Int J Nanomedicine. 2007;2(4):561-6.
2
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.
PLoS One. 2011;6(9):e24095. doi: 10.1371/journal.pone.0024095. Epub 2011 Sep 15.
3
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.
Antiviral Res. 2011 Jun;90(3):195-9. doi: 10.1016/j.antiviral.2011.03.186. Epub 2011 Apr 1.
4
Structure activity relationship of dendrimer microbicides with dual action antiviral activity.
PLoS One. 2010 Aug 23;5(8):e12309. doi: 10.1371/journal.pone.0012309.
5
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.
Antimicrob Agents Chemother. 2006 May;50(5):1696-700. doi: 10.1128/AAC.50.5.1696-1700.2006.
6
Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).
AIDS. 2011 May 15;25(8):1057-64. doi: 10.1097/QAD.0b013e328346bd3e.
7
Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.
Antiviral Res. 2005 Dec;68(3):139-46. doi: 10.1016/j.antiviral.2005.08.004. Epub 2005 Sep 27.
8
SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques.
AIDS Res Hum Retroviruses. 2005 Mar;21(3):207-13. doi: 10.1089/aid.2005.21.207.
9
Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study.
Sex Transm Dis. 2010 Feb;37(2):100-4. doi: 10.1097/OLQ.0b013e3181bc0aac.
10
Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
Med Res Rev. 2017 Jan;37(1):149-179. doi: 10.1002/med.21405. Epub 2016 Aug 12.
引用本文的文献
1
Evolution of branched peptides as novel biomaterials.
J Mater Chem B. 2025 Feb 12;13(7):2226-2241. doi: 10.1039/d4tb01897d.
2
Solubilization techniques used for poorly water-soluble drugs.
Acta Pharm Sin B. 2024 Nov;14(11):4683-4716. doi: 10.1016/j.apsb.2024.08.027. Epub 2024 Sep 2.
3
Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects.
Pharmaceuticals (Basel). 2024 May 22;17(6):668. doi: 10.3390/ph17060668.
4
Peptide Dendrimer-Based Antibacterial Agents: Synthesis and Applications.
ACS Infect Dis. 2024 Apr 12;10(4):1034-1055. doi: 10.1021/acsinfecdis.3c00624. Epub 2024 Mar 1.
5
Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis.
Acta Pharm Sin B. 2023 Nov;13(11):4417-4441. doi: 10.1016/j.apsb.2023.05.025. Epub 2023 May 26.
6
Functionalizing Dendrimers for Targeted Delivery of Bioactive Molecules to Macrophages: A Potential Treatment for Infection-A Review.
Pharmaceuticals (Basel). 2023 Oct 9;16(10):1428. doi: 10.3390/ph16101428.
7
Approved Nanomedicine against Diseases.
Pharmaceutics. 2023 Feb 26;15(3):774. doi: 10.3390/pharmaceutics15030774.
8
Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches.
Pharmaceutics. 2022 Dec 15;14(12):2818. doi: 10.3390/pharmaceutics14122818.
9
Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.
Viruses. 2022 Sep 14;14(9):2037. doi: 10.3390/v14092037.
10
Knee Osteoarthritis Therapy: Recent Advances in Intra-Articular Drug Delivery Systems.
Drug Des Devel Ther. 2022 May 4;16:1311-1347. doi: 10.2147/DDDT.S357386. eCollection 2022.
本文引用的文献
1
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.
Antimicrob Agents Chemother. 2006 May;50(5):1696-700. doi: 10.1128/AAC.50.5.1696-1700.2006.
2
Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses.
Antiviral Res. 2005 Dec;68(3):139-46. doi: 10.1016/j.antiviral.2005.08.004. Epub 2005 Sep 27.
3
A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.
J Infect Dis. 2005 Nov 1;192(9):1545-56. doi: 10.1086/462424. Epub 2005 Sep 26.
4
Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.
Mol Pharm. 2005 Jul-Aug;2(4):312-8. doi: 10.1021/mp050023q.
5
SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques.
AIDS Res Hum Retroviruses. 2005 Mar;21(3):207-13. doi: 10.1089/aid.2005.21.207.
6
In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission.
Antimicrob Agents Chemother. 2004 Oct;48(10):3834-44. doi: 10.1128/AAC.48.10.3834-3844.2004.
7
Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes.
Antimicrob Agents Chemother. 2003 Dec;47(12):3784-8. doi: 10.1128/AAC.47.12.3784-3788.2003.
8
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
Expert Opin Investig Drugs. 2002 Aug;11(8):1077-97. doi: 10.1517/13543784.11.8.1077.
Zotero 插件